Venus Remedies Reports Strong Profit Growth Amid Shift in Technical Trend
Venus Remedies, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation, reflecting a shift in technical trends. The company reported a significant increase in profit before tax and operating profit growth, alongside strong cash reserves and net sales, indicating a positive financial trajectory.
Venus Remedies, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical trend, moving from a mildly bearish stance to a sideways position. The company's financial metrics indicate a positive trajectory in several areas, including a notable growth rate in operating profit, which has increased at an annual rate of 98.02%. In the latest quarter, Venus Remedies reported a significant rise in profit before tax, which reached Rs 12.94 crore, marking a growth of 138.31%. Additionally, the company holds cash and cash equivalents at a robust Rs 78.43 crore, contributing to its healthy financial standing. The net sales for the quarter were reported at Rs 176.86 crore, reflecting a growth of 23.32%.
Despite a modest return of 1.56% over the past year, the stock's valuation remains attractive, with a price-to-book value of 0.9. The technical indicators suggest a lack of clear price momentum, which may influence investor sentiment moving forward.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
